NCT00002107View on ClinicalTrials.gov

A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Aldesleukin

Trial Locations (1)

94114

Davies Med Ctr / c/o HIV Institute, San Francisco

Sponsors

Lead Sponsor

Chiron Corporation
All Listed Sponsors
lead

Chiron Corporation

INDUSTRY